COST-EFFECTIVENESS ANALYSIS OF NEW ORAL ANTICOAGULANTS COMPARED TO WARFARIN IN THAI PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

被引：1
|
作者：
Dilokthornsakul, P. [1 ]
Nathisuwan, S. [2 ]
Krittayaphong, R. [2 ]
Chutinet, A. [3 ]
Permsuwan, U. [4 ]
机构：
[1] Naresuan Univ, Muang, Phitsanulok, Thailand
[2] Mahidol Univ, Bangkok, Thailand
[3] King Chulalongkorn Mem Hosp, Chulalongkorn Stroke Ctr, Thai Red Cross Soc, Bangkok, Thailand
[4] Chiang Mai Univ, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.234
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV40
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of non-Vitamin-K oral anticoagulants compared to warfarin in patients with non-valvular atrial fibrillation
    Harenberg, J.
    Krejczy, M.
    Wehling, M.
    Obermann, K.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1107 - 1107
  • [2] Cost-Effectiveness of Apixaban Compared to Other New Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation
    Rudakova, A. V.
    Tatarskiy, B. A.
    [J]. KARDIOLOGIYA, 2014, 54 (07) : 43 - 52
  • [3] COST-EFFECTIVENESS OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN COLOMBIA
    Garcia Pena, A. A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A829 - A830
  • [4] Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
    Dilokthornsakul, Piyameth
    Nathisuwan, Surakit
    Krittayaphong, Rungroj
    Chutinet, Aurauma
    Permsuwan, Unchalee
    [J]. HEART LUNG AND CIRCULATION, 2020, 29 (03): : 390 - 400
  • [5] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    [J]. Current Cardiology Reports, 2015, 17
  • [6] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    [J]. CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [7] Comparative cost-effectiveness of oral anticoagulants for stroke prevention in non-valvular atrial fibrillation patients in the UK
    Lip, G. Y. H.
    Lanitis, T.
    Kongnakorn, T.
    Phatak, H.
    Liu, L.
    Lawrence, J.
    Dorian, P.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 864 - 864
  • [8] COST-EFFECTIVENESS OF NOVEL ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN CHINA
    Guo, W.
    Tian, X.
    Li, W.
    Han, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S30 - S30
  • [9] COST-EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN CHINESE PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Chan, E.
    Li, X.
    Lau, C.
    Anand, S.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A866 - A867
  • [10] COST-EFFECTIVENESS OF APIXABAN COMPARED TO WARFARIN AND ASPIRIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) IN THE RUSSIAN FEDERATION
    Rudakova, A., V
    Parfenov, V. A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A489 - A489
12345